Met Life Investment Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 22,729 shares of MIRM stock, worth $1.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,729
Previous 22,729
-0.0%
Holding current value
$1.1 Million
Previous $777,000
14.03%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MIRM
# of Institutions
195Shares Held
54.1MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$319 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$218 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$167 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$157 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$149 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.79B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...